| BUSINESS STRATEGY | Co however, is "very committed to first-to-file patent challenges. "Litigation is part of the cost of doing business. Big pharma invests in R&D; generic companies spend on litigation to defend their own patented technologies," he adds |
| UPDATE | 09.02 |
| COMPANY | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |